The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acadia Pharmaceuticals Inc. | COM | 004225108 | 548,167 | 19,955,126 | SH | SOLE | 19,955,126 | 0 | 0 | ||
Achillion | COM | 00448Q201 | 1,374 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
Aegerion Pharmaceuticals | COM | 00767E102 | 70,339 | 820,275 | SH | SOLE | 820,275 | 0 | 0 | ||
Agios Pharmaceuticals | COM | 00847X104 | 5,592 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Ambit Biosciences Corp. | COM | 02318X100 | 11,593 | 747,962 | SH | SOLE | 747,962 | 0 | 0 | ||
Amicus Therapeutics | COM | 03152W109 | 1,195 | 515,072 | SH | SOLE | 515,072 | 0 | 0 | ||
Anacor Pharmaceuticals | COM | 32420101 | 9,308 | 876,463 | SH | SOLE | 876,463 | 0 | 0 | ||
Ariad Pharmaceuticals Inc. | COM | 04033A100 | 24,540 | 1,333,703 | SH | SOLE | 1,333,703 | 0 | 0 | ||
Array Biopharma Inc. | COM | 04269X105 | 9,330 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
Arrowhead Research Corp. | COM | 042797209 | 17,867 | 3,140,000 | SH | SOLE | 3,140,000 | 0 | 0 | ||
Avanir Pharmaceuticals | COM | 05348P401 | 18,733 | 4,428,591 | SH | SOLE | 4,428,591 | 0 | 0 | ||
Biocryst Pharmaceuticals Inc. | COM | 09058V103 | 48,776 | 6,699,979 | SH | SOLE | 6,699,979 | 0 | 0 | ||
BioDelivery Sciences Intl. Inc. | COM | 09060J106 | 4,594 | 846,005 | SH | SOLE | 846,005 | 0 | 0 | ||
Biomarin Pharmaceuticals | COM | 09061G101 | 56,532 | 783,311 | SH | SOLE | 783,311 | 0 | 0 | ||
Bluebird Bio Inc. | COM | 09609G100 | 3,007 | 111,521 | SH | SOLE | 111,521 | 0 | 0 | ||
Cerus | COM | 157085101 | 56,820 | 8,455,306 | SH | SOLE | 8,455,306 | 0 | 0 | ||
Chelsea Therapeutics | COM | 163428105 | 17,326 | 5,794,753 | SH | SOLE | 5,794,753 | 0 | 0 | ||
Chemocentryx Inc. | COM | 16383L106 | 1,112 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Clovis Oncology | COM | 189464100 | 18,346 | 301,744 | SH | SOLE | 301,744 | 0 | 0 | ||
Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | PFD CONV EX | 23254L207 | 177 | 20,979 | SH | SOLE | 20,979 | 0 | 0 | ||
Cubist Pharmaceuticals Inc. | COM | 229678107 | 318 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Derma Sciences | COM | 249827502 | 31,679 | 2,558,857 | SH | SOLE | 2,558,857 | 0 | 0 | ||
Discovery Laboratories Inc. | COM | 254668403 | 2,976 | 1,518,617 | SH | SOLE | 1,518,617 | 0 | 0 | ||
Enanta Pharmaceuticals | COM | 29251M106 | 2,865 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Epizyme Inc. | COM | 29428V104 | 800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Genomic Health Inc. | COM | 37244C101 | 417,442 | 13,650,835 | SH | SOLE | 13,650,835 | 0 | 0 | ||
Geron Corp. | COM | 374163103 | 3,350 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
Gilead Sciences Inc. | COM | 375558103 | 78,323 | 1,245,800 | SH | SOLE | 1,245,800 | 0 | 0 | ||
Halozyme Therapeutics Inc. | COM | 40637H109 | 77,474 | 7,017,608 | SH | SOLE | 7,017,608 | 0 | 0 | ||
Idera Pharmaceuticals Inc. | COM | 45168K306 | 10,205 | 5,865,000 | SH | SOLE | 5,865,000 | 0 | 0 | ||
Incyte Corp. | COM | 45337C102 | 565,023 | 14,810,559 | SH | SOLE | 14,810,559 | 0 | 0 | ||
Infinity Pharmaceuticals Inc. | COM | 45665G303 | 10,230 | 586,936 | SH | SOLE | 586,936 | 0 | 0 | ||
Insmed Inc. | COM | 457669307 | 14,764 | 945,803 | SH | SOLE | 945,803 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | COM | 45845P108 | 25,047 | 362,847 | SH | SOLE | 362,847 | 0 | 0 | ||
Ironwood Pharmaceuticals | COM | 46333X108 | 5,460 | 461,160 | SH | SOLE | 461,160 | 0 | 0 | ||
Isis Pharmaceuticals | COM | 464330109 | 9,274 | 247,036 | SH | SOLE | 247,036 | 0 | 0 | ||
Kythera Biopharmaceuticals | COM | 501570105 | 12,081 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
Ligand Pharmaceuticals Inc. | CLASS B | 53220K207 | 3,177 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
Medivation Inc. | COM | 58501N101 | 23,876 | 398,331 | SH | SOLE | 398,331 | 0 | 0 | ||
MEI Pharma, Inc. | COM | 55279B103 | 3,885 | 345,317 | SH | SOLE | 345,317 | 0 | 0 | ||
Mirati Therapeutics Inc. | COM | 60468T105 | 29,998 | 1,980,074 | SH | SOLE | 1,980,074 | 0 | 0 | ||
Novavax | COM | 670002104 | 5,408 | 1,716,913 | SH | SOLE | 1,716,913 | 0 | 0 | ||
Omeros Corp | COM | 682143102 | 5,932 | 608,404 | SH | SOLE | 608,404 | 0 | 0 | ||
Orasure Technologies Inc. | COM | 68554V108 | 1,463 | 243,467 | SH | SOLE | 243,467 | 0 | 0 | ||
Osiris Therapeutics Inc. | COM | 68827R108 | 6,245 | 375,282 | SH | SOLE | 375,282 | 0 | 0 | ||
Pharmacyclics Inc. | COM | 716933106 | 1,245,752 | 9,010,211 | SH | SOLE | 9,010,211 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | COM | 737010108 | 8,023 | 299,911 | SH | SOLE | 299,911 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 21,084 | 4,200,000 | SH | SOLE | 4,200,000 | 0 | 0 | ||
Prothena Corp. PLC | COM | G72800108 | 7,478 | 369,650 | SH | SOLE | 369,650 | 0 | 0 | ||
Puma Biotechnology | COM | 74587V107 | 5,366 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
QLT, Inc. | COM | 746927102 | 7,111 | 1,535,863 | SH | SOLE | 1,535,863 | 0 | 0 | ||
Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | 31,659 | 545,846 | SH | SOLE | 545,846 | 0 | 0 | ||
Receptos Inc. | COM | 756207106 | 2,597 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Repros Therapeutics | COM | 76028H209 | 74,468 | 2,778,654 | SH | SOLE | 2,778,654 | 0 | 0 | ||
Rigel Pharmaceuticals | COM | 766559603 | 1,790 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Salix Pharmaceuticals, Inc. | COM | 795435106 | 242 | 3,621 | SH | SOLE | 3,621 | 0 | 0 | ||
Sangamo | COM | 800677106 | 1,854 | 176,707 | SH | SOLE | 176,707 | 0 | 0 | ||
Seattle Genetics Inc. | COM | 812578102 | 846,925 | 19,322,947 | SH | SOLE | 19,322,947 | 0 | 0 | ||
Stemline Therapeutics Inc. | COM | 85858C107 | 36,255 | 800,400 | SH | SOLE | 800,400 | 0 | 0 | ||
Synageva Biopharma Corp. | COM | 87159A103 | 651,238 | 10,273,182 | SH | SOLE | 10,273,182 | 0 | 0 | ||
Synergy Pharmaceuticals | COM | 871639308 | 11,920 | 2,608,271 | SH | SOLE | 2,608,271 | 0 | 0 | ||
Synta Pharmaceuticals | COM | 87162T206 | 3,155 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Targacept | COM | 87611R306 | 10,984 | 2,068,186 | SH | SOLE | 2,068,186 | 0 | 0 | ||
Tesaro Inc. | COM | 881569107 | 1,209 | 31,218 | SH | SOLE | 31,218 | 0 | 0 | ||
TG Therapeutics | COM | 88322Q108 | 3,024 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
Threshold Pharma | COM | 885807206 | 8,614 | 1,852,399 | SH | SOLE | 1,852,399 | 0 | 0 | ||
United Therapeutics Corp. | COM | 91307C102 | 4,414 | 55,984 | SH | SOLE | 55,984 | 0 | 0 | ||
Vanda Pharmaceuticals, Inc. | COM | 921659108 | 52,463 | 4,791,179 | SH | SOLE | 4,791,179 | 0 | 0 | ||
Ventrus Biosciences, Inc. | COM | 922822101 | 3,514 | 1,215,840 | SH | SOLE | 1,215,840 | 0 | 0 | ||
Viropharma Inc. | COM | 928241108 | 219,551 | 5,592,239 | SH | SOLE | 5,592,239 | 0 | 0 | ||
Xenoport | COM | 98411C100 | 5,874 | 1,034,112 | SH | SOLE | 1,034,112 | 0 | 0 | ||
Xoma Corp. | COM | 98419J107 | 103,415 | 23,032,372 | SH | SOLE | 23,032,372 | 0 | 0 | ||
Ziopharm Oncology Inc. | COM | 98973P101 | 1,002 | 254,199 | SH | SOLE | 254,199 | 0 | 0 | ||
Zogenix, Inc. | COM | 98978L105 | 3,704 | 2,001,000 | SH | SOLE | 2,001,000 | 0 | 0 | ||
Auxilium 1.5% 7/15/2018 | CONV BONDS | 05334DAA5 | 90,247 | 87,090,000 | PRN | SOLE | 87,090,000 | 0 | 0 | ||
Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | 82,032 | 22,898,000 | PRN | SOLE | 22,898,000 | 0 | 0 | ||
Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | 59,528 | 21,500,000 | PRN | SOLE | 21,500,000 | 0 | 0 | ||
Incyte Genomics Notes 4.75% 10/1/2015 | CONV BONDS | 45337CAH5 | 688,121 | 157,758,000 | PRN | SOLE | 157,758,000 | 0 | 0 | ||
Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | 20,042 | 16,860,000 | PRN | SOLE | 16,860,000 | 0 | 0 | ||
Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | 58,425 | 41,000,000 | PRN | SOLE | 41,000,000 | 0 | 0 | ||
Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | 55,559 | 39,500,000 | PRN | SOLE | 39,500,000 | 0 | 0 | ||
Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | 335,332 | 219,440,000 | PRN | SOLE | 219,440,000 | 0 | 0 |